2002
DOI: 10.1097/00000539-200201000-00018
|View full text |Cite
|
Sign up to set email alerts
|

Intravenous Fentanyl Increases Natural Killer Cell Cytotoxicity and Circulating CD16+ Lymphocytes in Humans

Abstract: Many previous studies have suggested that opioid drugs can impair immune resistance in patients who may be at risk for infection. This study suggests that the opioid fentanyl, when given to healthy humans without coexisting diseases, does not suppress immune resistance. On the basis of these results, the use of fentanyl should not be restricted because of concerns that it may suppress immune function.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
37
0
8

Year Published

2003
2003
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 53 publications
(46 citation statements)
references
References 14 publications
1
37
0
8
Order By: Relevance
“…In addition to the hormone-mediated "indirect" modulation of cell proliferation, opioids modify T-and B-cell responses (Guan et al, 1997;Shahabi et al, 2000;Beagles et al, 2004;Roy et al, 2004), macrophage and microglial activity (Belkowski et al, 1995;Hu et al, 2000;Hu et al, 2002), chemotaxis (Szabo et al, 2002), cell migration (Patel et al, 2003), and natural killer cell cytotoxicity (Hsueh et al, 1996;Boyadjieva et al, 2001;Yeager et al, 2002) by modifying cytokine and chemokine release (Belkowski et al, 1995;Alicea et al, 1996;Kong et al, 1997;Wetzel et al, 2000b;Sacerdote, 2003), respective receptor expression (Zhang and Rogers, 2000), and chemokine receptor responsiveness (Grimm et al, 1998a;Rogers et al, 2000;Szabo et al, 2002Szabo et al, , 2003Chen et al, 2004) (for review, see McCarthy et al, 2001 and. These effects do not necessarily affect survival of the opioid-stimulated cell but may modify the course of inflammatory and infectious diseases, such as HIV infection, and thereby survival of the organism.…”
Section: B Chemokine-and Cytokine-mediated Effectsmentioning
confidence: 99%
See 1 more Smart Citation
“…In addition to the hormone-mediated "indirect" modulation of cell proliferation, opioids modify T-and B-cell responses (Guan et al, 1997;Shahabi et al, 2000;Beagles et al, 2004;Roy et al, 2004), macrophage and microglial activity (Belkowski et al, 1995;Hu et al, 2000;Hu et al, 2002), chemotaxis (Szabo et al, 2002), cell migration (Patel et al, 2003), and natural killer cell cytotoxicity (Hsueh et al, 1996;Boyadjieva et al, 2001;Yeager et al, 2002) by modifying cytokine and chemokine release (Belkowski et al, 1995;Alicea et al, 1996;Kong et al, 1997;Wetzel et al, 2000b;Sacerdote, 2003), respective receptor expression (Zhang and Rogers, 2000), and chemokine receptor responsiveness (Grimm et al, 1998a;Rogers et al, 2000;Szabo et al, 2002Szabo et al, , 2003Chen et al, 2004) (for review, see McCarthy et al, 2001 and. These effects do not necessarily affect survival of the opioid-stimulated cell but may modify the course of inflammatory and infectious diseases, such as HIV infection, and thereby survival of the organism.…”
Section: B Chemokine-and Cytokine-mediated Effectsmentioning
confidence: 99%
“…However, based on the literature it appears reasonable to suggest that the release of endogenous opioids is aimed at inhibiting exaggerated inflammatory reactions (Gironi et al, 2000;Takeba et al, 2001;Philippe et al, 2003) and inflammatory pain (Cabot et al, 1997(Cabot et al, , 2001Machelska et al, 2002) whereas NK cell-mediated defense mechanisms against tumor cells or invading microorganisms are supported (Hsueh et al, 1995(Hsueh et al, , 1996Kowalski, 1997;Boyadjieva et al, 2001;Yeager et al, 2002).…”
Section: A Inhibition Of Inflammation With Endogenous Opioidsmentioning
confidence: 99%
“…Suppression was not seen with 0.1 mg morphine, also suggesting a dose-dependent effect. 28 Fentanyl administration has been associated with a transient increase in NK cell numbers, 29 a dosedependent reduction in NK cell activity, 30 or no reduction. 31 Remifentanil was not found to impair NK cell activity in healthy volunteers.…”
Section: Opioidsmentioning
confidence: 99%
“…La suppression n'a pas été observée avec une dose de 0,1 mg de morphine, suggérant un effet dose-dépendant. 28 L'administration de fentanyl a été associée à une augmentation transitoire du nombre de cellules NK, 29 une réduction dose-dépendante de l'activité des cellules NK 30 ou à une absence de réduction. 31 Le remifentanil n'a pas paru perturber l'activité des cellules NK chez des volontaires en bonne santé.…”
Section: Morphiniquesunclassified
“…This difference may be secondary to the µ3 receptor, which is not bind by synthetic opioids such as fentanyl [119]. Although suppressive effects of fentanyl on NK cell have been reported in animals [120], in humans it has shown that fentanyl increases activity and number of NK cells, and CD8 + cytotoxic T-lymphocytes [121]. However, neither polymorphonuclear cells (PMNC) activity [122] nor cellular adhesion is affected [123].…”
mentioning
confidence: 99%